202 related articles for article (PubMed ID: 20418300)
21. Use of dexmedetomidine in children after cardiac and thoracic surgery.
Chrysostomou C; Di Filippo S; Manrique AM; Schmitt CG; Orr RA; Casta A; Suchoza E; Janosky J; Davis PJ; Munoz R
Pediatr Crit Care Med; 2006 Mar; 7(2):126-31. PubMed ID: 16446599
[TBL] [Abstract][Full Text] [Related]
22. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis.
Potts AL; Anderson BJ; Warman GR; Lerman J; Diaz SM; Vilo S
Paediatr Anaesth; 2009 Nov; 19(11):1119-29. PubMed ID: 19708909
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia.
Zhong W; Zhang Y; Zhang MZ; Huang XH; Li Y; Li R; Liu QW
J Clin Pharm Ther; 2018 Jun; 43(3):414-421. PubMed ID: 29247451
[TBL] [Abstract][Full Text] [Related]
24. Dose Escalation Pharmacokinetic Study of Intranasal Atomized Dexmedetomidine in Pediatric Patients With Congenital Heart Disease.
Grogan K; Thibault C; Moorthy G; Prodell J; Nicolson SC; Zuppa A
Anesth Analg; 2023 Jan; 136(1):152-162. PubMed ID: 35446797
[TBL] [Abstract][Full Text] [Related]
25. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study.
Miller JW; Balyan R; Dong M; Mahmoud M; Lam JE; Pratap JN; Paquin JR; Li BL; Spaeth JP; Vinks A; Loepke AW
Br J Anaesth; 2018 May; 120(5):1056-1065. PubMed ID: 29661383
[TBL] [Abstract][Full Text] [Related]
26. Dexmedetomidine hemodynamics in children after cardiac surgery.
Potts AL; Anderson BJ; Holford NH; Vu TC; Warman GR
Paediatr Anaesth; 2010 May; 20(5):425-33. PubMed ID: 20337956
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of dexmedetomidine in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass.
Kim EH; Choi BM; Kang P; Lee JH; Kim HS; Jang YE; Ji SH; Noh GJ; Cho JY; Kim JT
Paediatr Anaesth; 2023 Apr; 33(4):303-311. PubMed ID: 36594749
[TBL] [Abstract][Full Text] [Related]
28. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery?
Chrysostomou C; Sanchez De Toledo J; Avolio T; Motoa MV; Berry D; Morell VO; Orr R; Munoz R
Pediatr Crit Care Med; 2009 Nov; 10(6):654-60. PubMed ID: 19295456
[TBL] [Abstract][Full Text] [Related]
29. Dexmedetomidine Clearance Decreases with Increasing Drug Exposure: Implications for Current Dosing Regimens and Target-controlled Infusion Models Assuming Linear Pharmacokinetics.
Alvarez-Jimenez R; Weerink MAS; Hannivoort LN; Su H; Struys MMRF; Loer SA; Colin PJ
Anesthesiology; 2022 Feb; 136(2):279-292. PubMed ID: 34851425
[TBL] [Abstract][Full Text] [Related]
30. A Population Pharmacokinetic Model of Intravenous Dexmedetomidine for Mechanically Ventilated Children after Neurosurgery.
Song IK; Yi S; Lim HS; Lee JH; Kim EH; Cho JY; Kim MC; Kim JT; Kim HS
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31581476
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and Sedative Effects of Intranasal Dexmedetomidine in Ambulatory Pediatric Patients.
Uusalo P; Guillaume S; Siren S; Manner T; Vilo S; Scheinin M; Saari TI
Anesth Analg; 2020 Apr; 130(4):949-957. PubMed ID: 31206433
[TBL] [Abstract][Full Text] [Related]
32. Clinical uses of dexmedetomidine in pediatric patients.
Phan H; Nahata MC
Paediatr Drugs; 2008; 10(1):49-69. PubMed ID: 18162008
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension.
Barr FE; Tirona RG; Taylor MB; Rice G; Arnold J; Cunningham G; Smith HA; Campbell A; Canter JA; Christian KG; Drinkwater DC; Scholl F; Kavanaugh-McHugh A; Summar ML
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):319-26. PubMed ID: 17662768
[TBL] [Abstract][Full Text] [Related]
34. Effects of mild hypoalbuminemia on the pharmacokinetics and pharmacodynamics of dexmedetomidine in patients after major abdominal or thoracic surgery.
Zhang T; Deng Y; He P; He Z; Wang X
J Clin Anesth; 2015 Dec; 27(8):632-7. PubMed ID: 26277872
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and sedative effects of dexmedetomidine in dairy calves.
Cagnardi P; Villa R; Ravasio G; Lucatello L; Di Cesare F; Capolongo F; Boccardo A; Pravettoni D
N Z Vet J; 2017 Jan; 65(1):14-18. PubMed ID: 27643584
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and pharmacodynamic study of dexmedetomidine in elderly patients during spinal anesthesia.
Kuang Y; Zhang RR; Pei Q; Tan HY; Guo CX; Huang J; Xiang YX; Ouyang W; Duan KM; Wang SY; Yang GP
Int J Clin Pharmacol Ther; 2015 Dec; 53(12):1005-14. PubMed ID: 26413731
[TBL] [Abstract][Full Text] [Related]
37. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine.
Weerink MAS; Struys MMRF; Hannivoort LN; Barends CRM; Absalom AR; Colin P
Clin Pharmacokinet; 2017 Aug; 56(8):893-913. PubMed ID: 28105598
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetic analysis of dexmedetomidine in children using real-world data from electronic health records and remnant specimens.
James NT; Breeyear JH; Caprioli R; Edwards T; Hachey B; Kannankeril PJ; Keaton JM; Marshall MD; Van Driest SL; Choi L
Br J Clin Pharmacol; 2022 Jun; 88(6):2885-2898. PubMed ID: 34957589
[TBL] [Abstract][Full Text] [Related]
39. The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors.
Wiczling P; Bartkowska-Śniatkowska A; Szerkus O; Siluk D; Rosada-Kurasińska J; Warzybok J; Borsuk A; Kaliszan R; Grześkowiak E; Bienert A
J Pharmacokinet Pharmacodyn; 2016 Jun; 43(3):315-24. PubMed ID: 27221375
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics of dexmedetomidine in critically ill patients.
Välitalo PA; Ahtola-Sätilä T; Wighton A; Sarapohja T; Pohjanjousi P; Garratt C
Clin Drug Investig; 2013 Aug; 33(8):579-87. PubMed ID: 23839483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
